Endocrinology of male infertility: evaluating hormonal imbalance in infertile males with oligozoospermia
Endocrinology of male infertility
DOI:
https://doi.org/10.52442/jrmi.v11i3.799Keywords:
Male Infertility, Hormonal Imbalances, Hypogonadism, Oligospermia, Oligozoospermia, Partial Androgen ResistanceAbstract
Introduction: The male factor has become more significant in recent years and accounts for about half of the cases of infertility. Hormonal imbalance has significant contribution in causing infertility among oliogozoospermic males.
Objective: To evaluate hormonal imbalance contributing to infertility in males with oligozoospermia.
Materials and Methods: A retrospective cross-sectional study was conducted at the Department of Special Chemistry and Microbiology, Shalamar Institute of Health Sciences, Lahore, from January 2022 to February 2024. Data of 113 infertile males aged 18–50 years with sperm concentration <15 million/ml were retrieved from the hospital information system using convenient sampling. Hormonal profiles including LH, FSH, testosterone, prolactin, and TSH were recorded along with clinical details. Quantitative data were analyzed as means and standard deviations, qualitative data as frequencies and percentages. Statistical analysis was performed using SPSS v25, with p<0.05 considered significant.
Results: Mean age of the infertile males (n=113) was 32±7.87 years. Evaluation of hormonal profiles in infertile males with oligospermia revealed normal hormonal profile (testosterone, FSH, LH, TSH and prolactin) in 65 (57.52%) males. Twenty-one (18.58%) had secondary hypogonadism, while oligospermia, primary spermatogenic failure and partial androgen resistance was seen in 6-7% of individuals. All the hormonal imbalances showed no statistically significant difference with respect to sperm concentration (p >0.05) except for partial androgen resistance (p=0.033).
Conclusion: Hormonal imbalances have significant contribution in causing infertility among oligozoospermic males. It is imperative to conduct a prompt hormonal evaluation of the male factor, as certain causes of male infertility remain unclear despite advancements in diagnosis.
References
Leslie S.W., Taylor L., Sutton S., AB M. Male Infertility. Statpearls. Feb 25, 2024. https://www.ncbi.nlm.nih.gov/books/NBK562258/
Schlegel PN, Sigman M, Collura B, De Jonge CJ, Eisenberg ML, Lamb DJ, et al. Diagnosis and Treatment of Infertility in Men: AUA/ASRM Guideline Part I. J Urol. 2021 Jan; 205(1): 36-43. Doi: 10.1016/j.fertnstert.2020.11.016.
Shih KW, Shen PY, Wu CC, Kang YN. Testicular versus percutaneous epididymal sperm aspiration for patients with obstructive azoospermia: a systematic review and meta-analysis. Transl Androl Urol. 2019 Dec; 8(6): 631-40. Doi: 10.21037/tau.2019.11.20.
Barak S, Baker HWG. Clinical Management of Male Infertility. In: Feingold KR, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E, et al., editors. Endotext [Internet]. MDText.com, Inc.; South Dartmouth (MA): Feb 5, 2016.
Concepción-Zavaleta M, Paz Ibarra JL, Ramos-Yataco A, Coronado-Arroyo J, Concepción-Urteaga L, Roseboom PJ, et al. Assessment of hormonal status in male infertility. An update. Diabetes Metab Syndr. 2022; 16(3): 102447. Doi: org/10.1016/j.dsx.2022.102447.
Ferlin A, Garolla A, Ghezzi M, Selice R, Palego P, Caretta N, et al. Sperm Count and Hypogonadism as Markers of General Male Health. Eur Urol Focus. 2021;7(1): 205–13. Doi: 10.1016/j.euf.2019.08.001.
Yuan J, Jin L, Wang M, Wei S, Zhu G, Xu B. Detection of chromosome aberrations in 17 054 individuals with fertility problems and their subsequent assisted reproductive technology treatments in Central China. Hum Reprod. 2023; 38(Supplement_2): ii34–ii46. Doi: 10.1093/humrep/dead076.
Bach PV, Patel N, Najari BB, Oromendia C, Flannigan R, Brannigan R, et al. Changes in practice patterns in male infertility cases in the United States: the trend toward sub specialization. Fertil Steril. 2018 Jul 01; 110 (1): 76-82. Doi: 10.1016/j.fertnstert.2018.03.020.
AlShareef S, Gokarakonda SB, Marwaha R. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): Jun 20, 2023. https://www.ncbi.nlm.nih.gov/books/NBK482418/
Sengupta P, Dutta S, Krajewska-Kulak E. The Disappearing Sperms: Analysis of Reports Published Between 1980 and 2015. Am J Mens Health. 2017 Jul;11(4):1279-304. Doi: 10.1177/1557988316643383.
Levine H, Jørgensen N, Martino-Andrade A, Mendiola J, Weksler-Derri D, Jolles M, et al. Temporal trends in sperm count: a systematic review and meta-regression analysis of samples collected globally in the 20th and 21st centuries. Hum Reprod Update. 2023 Mar 01; 29(2):157-76. Doi: 10.1093/humupd/dmac035.
Chen T, Belladelli F, Del Giudice F, Eisenberg ML. Male fertility as a marker for health. Reprod Biomed Online. 2022 Jan; 44(1): 131-44. Doi: 10.1016/j.rbmo.2021.09.023.
Del Giudice F, Kasman AM, Ferro M, Sciarra A, De Berardinis E, Belladelli F, et al. Clinical correlation among male infertility and overall male health: A systematic review of the literature. Investig Clin Urol. 2020 Jul; 61(4):355-71. doi: 10.4111/icu.2020.61.4.355.
Olesen IA, Andersson AM, Aksglaede L, Skakkebaek NE, Rajpert-de Meyts E, Joergensen N, et al. Clinical, genetic, biochemical, and testicular biopsy findings among 1,213 men evaluated for infertility. Fertil Steril. 2017 Jan; 107(1) :74-82. Doi: 10.1016/j.fertnstert.2016.09.015.
Ahmed FK, Khan TA, Yahya U. Prevalence Causes, and Contributing Factors of Male Infertility in Pakistan. Front Health Inform. 2024; 13 (3): 10707-712.
WHO laboratory manual for the examination and processing of human semen, 6th ed. 27 July 2021. https://www.who.int/publications/i/item/9789240030787
Vogiatzi MG. Hypogonadism Workup. Medscape. Mar 22, 2024. https://emedicine.medscape.com/article/922038-workup?form=fpf#c4
Livingston M, Jones R, Hackett G, Donnahey G, Yc Moreno G, Duff CJ, et al. Screening for Hypogonadism in Primary Healthcare: How to do this effectively. Exp Clin Endocrinol Diabetes. 2018 Jan 24; 126(3):176-81. Doi: 10.1055/s-0043-114866.
Dwyer AA, McDonald IR, Cangiano B, et al. Classes and predictors of reversal in male patients with congenital hypogonadotropic hypogonadism: a cross-sectional study of six international referral centres. Lancet Diabetes Endocrinol. 2024 Apr. 12 (4):257-66. Doi: 10.1016/S2213-8587(24)00028-7.
Nieschlag E, Bouloux P-MG, Stegmann BJ, Shankar RR, Guan Y, Tzontcheva A, et al. An open-label clinical trial to investigate the efficacy and safety of corifollitropin alfa combined with hCG in adult men with hypogonadotropic hypogonadism. Reprod Biol Endocrinol. 2017 Mar 7; 15(1):17. Doi: 10.1186/s12958-017-0232-y.
Jungwirth A, Diemer T, Kopa Z, Krausz C, Minhas S, Tournaye H. Male Infertility. European Association of Urology. Available from: http://uroweb.org/guideline/male-infertility/.2017; Accessed: June 6, 2020
Tharakan T, Corona G, Foran D, Salonia A, Sofikitis N, Giwercman A, et al. Does hormonal therapy improve sperm retrieval rates in men with non-obstructive azoospermia: a systematic review and meta-analysis. Hum Reprod Update. 2022 Aug 25. 28(5): 609-28. Doi: 10.1093/humupd/dmac016.
Flannigan R, Najafabadi BT, Violette PD, Jarvi K, Patel P, Bach PV, et al. 2023 Canadian Urological Association guideline: Evaluation and management of azoospermia. Can Urol Assoc J. 2023 Jun 15; 17(8):228-40. Doi: 10.5489/cuaj.8445.
Schlegel PN, Sigman M, Collura B, De Jonge CJ, Eisenberg ML, Lamb DJ, et al. Diagnosis and treatment of infertility in men: AUA/ASRM guideline part I. Fertil Steril. 2021 Jan; 115(1):54-61. Doi: 10.1097/JU.0000000000001521.
Dave CN. Male Infertility Guidelines. Medscape. Nov 9, 2023. https://emedicine.medscape.com/article/436829-guidelines
2023 European Association of Urology (EAU) Guideline: Sexual and Reproductive Health- Male Infertility. EAU Guidelines. Edn. presented at the EAU Annual Congress, Madrid 2025. ISBN 978-94-92671-29-5.
Sharma M, Leslie SW. Azoospermia. [Updated 2023 Nov 18]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK578191/
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Journal of Rehman Medical Institute
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
